Marion County judge dismisses Indiana abortion records lawsuit
Superior Court Judge Timothy Oakes ruled in favor of the Indiana Department of Health, which stopped sharing the reports following the state’s adoption of a near-total abortion ban.
Health Care & Insurance
Articles
Teen vaping hits 10-year low in United States
FDA officials noted that the drop in vaping didn’t coincide with a rise in other tobacco industry products, such as nicotine pouches, which have surged in use among adults.
Nearly 2,000 drug plants overdue for FDA checks after COVID delays, analysis finds
Last year’s inspection numbers were down almost 40% from the pre-pandemic period, when the FDA averaged about 4,300 annual inspections.
Boar’s Head plant linked to deadly outbreak broke food safety rules dozens of times, records show
The plant has been linked to the deaths of at least nine people and hospitalizations of about 50 others in 18 states, including Indiana.
Lilly now selling vials of blockbuster Zepbound at 50% discount
Lilly said its new option will help millions of adults with obesity access the medicine they need, including those not eligible for the Zepbound savings card program, those without employer coverage, and those who need to self-pay outside of insurance.
MBX Biosciences files intention to go public
The five-year-old, clinical-stage drugmaker has already raised more than $213 million to develop therapeutics to treat rare endocrine disorders, a huge amount for a startup.
FDA approves updated COVID-19 vaccines; shots should be available in days
With the Food and Drug Administration’s clearance, Pfizer and Moderna are set to begin shipping millions of doses.
Medicaid advisory panel weighs in on HIP lawsuit, PathWays transition
Legislators on the state’s Medicaid Advisory Committee spent hours Wednesday questioning state officials about Indiana’s ongoing lawsuit over provisions of the Healthy Indiana Plan.
Study: Lilly’s Zepbound cut risk of diabetes by 94% in obese people
The longest continuous study of Indianapolis-based Lilly’s drug Zepbound to date included more than 1,000 patients.
Lilly opens new 12-story, $700M R&D center in Boston
Lilly is moving about 200 scientists and researchers who had worked in nearby Cambridge, Massachusetts, to the new center, and plans to add about 300 employees.
IU med school grad gifts $5M to support new anatomy lab
The lab, which will be located on the second floor of the 11-story IU Medical Education and Research Building, will emphasize hands-on physical dissection as a vital component of medical training.
Purdue, Lilly establish medical-focused research center
The Eli Lilly and Co. and Purdue University Research Alliance Center involves more than 50 researchers and 65 graduate students.
Eli Lilly taps blue-chip bond market to fund Morphic acquisition
Lilly is buying Morphic for $3.2 billion to gain experimental therapies for inflammatory bowel disease and other chronic illnesses.
Rokita dismisses IU Health privacy case
Indiana Attorney General Todd Rokita’s office in its own dismissal filing said the case was no longer necessary because discovery in the case has shown IU Health has taken actions to satisfy deficiencies in its policies.
Indiana, 14 other states sue to block Biden effort to help migrants get health coverage
The states hope to block a rule that is expected to allow 100,000 immigrants brought to the U.S. illegally as children to enroll next year in the federal Affordable Care Act’s health insurance.
Novo Nordisk’s Wegovy sales hit by competition from Eli Lilly
Novo is vying with Indianapolis-based Lilly for supremacy in the pharmaceutical industry’s fastest-growing new business, obesity drugs. The market is expected to reach $130 billion by the end of the decade.
Highly anticipated Indiana All Payer Claims Database launched
The Indiana All Payer Claims Database website is expected to provide transparency to health care costs and allow consumers to compare prices across multiple health systems.
Fast-growing MBX Biosciences raises another $63.5 million in funding
MBX is focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic disorders, such as hypoparathyroidism, post-bariatric hypoglycemia and obesity.
Tech startup Arrive recruits former Carmel mayor, Elevance CFO
The two additions could help Arrive AI—a maker of smart mailboxes with security and temperature-control features—to gain more traction with municipalities and health care providers.
Charitable care from Hoosier not-for-profit hospitals remains stagnant while revenue increases
Meanwhile, health care systems continue to send thousands of Hoosiers to court over unpaid sums as small as $250.